UNPLUGGED Schools Grant Act of 2025

House Bill

H.R. 4005

119th Congress

UNPLUGGED Schools Grant Act of 2025

In Committee

Introduced:Jun 12, 2025

Primary Sponsor

Doris O. Matsui

Representative

Democratic

CA-7

Cosponsors

2

Quick Stats

Policy Area

Health

Summary

The Naloxone Affordability Act of 2023 requires the Government Accountability Office to study the accessibility and affordability of naloxone, a medication that can temporarily reverse opioid overdoses. The bill addresses concerns about the rising cost of naloxone now that it is available without a prescription, which means it is no longer covered by most health insurance plans.

Latest Action

Referred to the Subcommittee on Health.

SponsorDoris O. Matsui (D-CA)

Introduced6/12/2025

StatusReferred to the House Committee on Education and Workforce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

UNPLUGGED Schools Grant Act of 2025

The Naloxone Affordability Act of 2023 requires the Government Accountability Office to study the accessibility and affordability of naloxone, a medication that can temporarily reverse opioid overdoses. The bill addresses concerns about the rising cost of nalo

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The Naloxone Affordability Act of 2023 requires the Government Accountability Office to study the accessibility and affordability of naloxone, a medication that can temporarily reverse opioid overdoses. The bill addresses concerns about the rising cost of naloxone now that it is available without a prescription, which means it is no longer covered by most health insurance plans.

Bill Number: 4005
Sponsor: Doris O. Matsui (D-CA)
Introduced: 6/12/2025
Status: Referred to the House Committee on Education and Workforce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: UNPLUGGED Schools Grant Act of 2025
Bill Number: 4005
Sponsor: Doris O. Matsui (D-CA)
Status: Referred to the House Committee on Education and Workforce.
Introduced: 6/12/2025
Summary: The Naloxone Affordability Act of 2023 requires the Government Accountability Office to study the accessibility and affordability of naloxone, a medication that can temporarily reverse opioid overdoses. The bill addresses concerns about the rising cost of naloxone now that it is available without a

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

The Naloxone Affordability Act of 2023 requires the Government Accountability Office to study the accessibility and affordability of naloxone, a medication that can temporarily reverse opioid overdoses. The bill addresses concerns about the rising cost of naloxone now that it is available without a prescription, which means it is no longer covered by most health insurance plans.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Naloxone Affordability Act of 2023 This bill requires the Government Accountability Office to study access to and affordability of naloxone (a medication that temporarily reverses opioid overdoses). The study must address matters related to out-of-pocket costs that consumers pay for naloxone and coverage for naloxone as an over-the-counter drug through Medicare, Medicaid, and private health insurance. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved Narcan (a naloxone hydrochloride nasal spray) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.

Key Points

Main provisions of the bill

The bill directs the GAO to examine out-of-pocket costs for consumers purchasing naloxone, as well as insurance coverage for naloxone through Medicare, Medicaid, and private plans.
Naloxone used to require a prescription, meaning it was typically covered by health insurance. However, the FDA recently approved an over-the-counter version, which is not generally covered by insurance.
The goal of the bill is to understand the financial barriers preventing wider access to this life-saving medication, especially for low-income individuals and families.

How This Impacts Americans

Potential effects on citizens and communities

If enacted, this bill would directly impact individuals at risk of opioid overdose, as well as their families and communities. Improving access to affordable naloxone could save lives by empowering more people to respond effectively to overdose emergencies. The findings from the GAO study could also inform future policies to ensure naloxone remains accessible and affordable, especially for vulnerable populations.

Policy Areas

Primary Policy Area

Health

Related Subjects

Congressional oversight

Drug therapy

Drug, alcohol, tobacco use

Government studies and investigations

Health care costs and insurance

Health care coverage and access

Medicaid

Medicare

Prescription drugs

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4005, 119th Congress (2025). "UNPLUGGED Schools Grant Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4005

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.